HG-1436

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1436

Drug Alias NameHFXJW408 modulator (Human Genome Sciences)KIAA1253 modulator (Human Genome Sciences)SERINC1 modulator (Human Genome Sciences)serine incorporator 1 modulator (Human Genome Sciences)tumor differentially expressed 2 modulator (Human Genome Sciences) +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsNervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A